fda semaglutide shortage status january 2025 drug list FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize-mvanhaasteren.nl FDA Issues Order on Resolution

Introducing Retatrutide Advanced Metabolic Peptide Therapy (60mg / 5ml)

Popular GLP-1 medications such as Ozempic may carry an unexpected link to a lower risk of epilepsy in people with type 2 diabetes.

Wegovyis the brand name forsemaglutide 2.4 mg, a medication developed by Novo Nordisk for chronic weight management

It works by combining two medicines Naltrexone, which helps reduce food cravings, and Bupropion, which helps control appetite and support long-term weight loss habits

Second, over over-half of health plans focus on member communications, informing health plan enrollees on alternative options to the expensive drugs

As the GLP-1 medications gain traction among consumers, manufacturers have a unique opportunity to tap into evolving dietary preferences.